{
  "ticker": "JNJ",
  "target_date": "2025-08-21",
  "actual_date": "2025-08-21",
  "collected_at": "2025-12-08T12:10:23.915020",
  "price": {
    "open": 176.13,
    "high": 177.64,
    "low": 175.75,
    "close": 176.5055389404297,
    "volume": 8859600,
    "change_1d_pct": 0.05,
    "change_7d_pct": 3.56,
    "change_30d_pct": 13.47
  },
  "technicals": {
    "rsi_14": 87.76,
    "sma_20": 169.84,
    "sma_50": 160.94,
    "macd": 4.232,
    "macd_signal": 3.974,
    "macd_histogram": 0.258,
    "bb_upper": 178.31,
    "bb_lower": 161.36,
    "price_vs_sma20_pct": 3.93,
    "price_vs_sma50_pct": 9.67,
    "volume_ratio": 1.04
  },
  "fundamentals": {
    "market_cap": 488103673856,
    "pe_ratio": 19.555204,
    "forward_pe": 19.112444,
    "price_to_book": 6.1490245,
    "price_to_sales": 5.2973695,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.5,
    "pct_from_52w_low": 44.02
  },
  "macro": {
    "spy": {
      "price": 633.79,
      "change_1d_pct": -0.4,
      "change_7d_pct": -1.45
    },
    "vix": {
      "level": 16.6,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.33
    },
    "dollar_index": {
      "level": 98.62
    },
    "gold": {
      "price": 3336.9
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q2 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1755818681,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=58c187a768f5bc4c3434410510e342c2b411f0a5ea7e700bddd565110013faf7"
    },
    {
      "headline": "Johnson & Johnson Shares Rally as Pharma Giant Invests $2 Billion in U.S. Expansion",
      "source": "Yahoo",
      "datetime": 1755802156,
      "summary": "JNJ Stock Moves Higher as Pharma Leader Strengthens Domestic Supply Chain",
      "url": "https://finnhub.io/api/news?id=0385536056b028d93490548811fa542756de1ca0a9e0024f48f26453633cbcde"
    },
    {
      "headline": "[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentat",
      "source": "Yahoo",
      "datetime": 1755793800,
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Biologics and Biosimilars Market size & share revenue was valued at approximately USD 478.83 Billion in 2024 and is expected to reach USD 527.36 Billion in 2025 and is e",
      "url": "https://finnhub.io/api/news?id=9aaef2be70e1f2d712f1b47c8b1dce64987548f13e4fff641e2d6a7b53569d78"
    },
    {
      "headline": "J&J signs $2bn incumbency deal at CDMO Fujifilm\u2019s new hub",
      "source": "Yahoo",
      "datetime": 1755791935,
      "summary": "The deal is part of a wider $55bn investment strategy by J&J to bolster US manufacturing amid pressure from Trump.",
      "url": "https://finnhub.io/api/news?id=615a33857129581ee822ff8224aa506412088defdb6ac986dd8c38eca6a1767c"
    },
    {
      "headline": "US-EU trade deal impacts on pharma industry more 'manageable' than expected",
      "source": "Yahoo",
      "datetime": 1755790362,
      "summary": "A trade deal framework between the US and EU is causing less pain than anticipated for pharma.",
      "url": "https://finnhub.io/api/news?id=b2d3563e71b4a5f4a3af88b9e03d3e16afa04b85b3be2d415daa356edef90535"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-08-18",
      "description": "xslF345X05/wk-form4_1755555550.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000180/xslF345X05/wk-form4_1755555550.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    },
    {
      "form": "8-K",
      "date": "2025-07-16",
      "description": "jnj-20250716.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}